Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$179.86 - $214.88 $650,553 - $777,220
-3,617 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$170.47 - $211.93 $15,342 - $19,073
90 Added 2.55%
3,617 $649,000
Q4 2020

Feb 17, 2021

SELL
$101.87 - $151.79 $54.2 Million - $80.7 Million
-531,836 Reduced 99.34%
3,527 $535,000
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $54.5 Million - $81.3 Million
535,363 New
535,363 $535,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.